INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

66,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
KC
Kozlik ChristenChief Accounting Officer
ACELAccel Entertainment, Inc.
Open-market sale
SELL$6,353
550 sh
Sep 15, 2026Sep 17, 2026
Page 314 of 1668
← PrevNext →
traded Sep 15, 2026
+2d
SEC Form 4

Evidence

25
RA
Rieger AprilChief Lgl. & Admin Ofc., Sec
NCNOnCino, Inc.
Open-market sale
SELL$134K
6,098 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

24
HA
How AntoinetteChief Accounting Officer
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$376K
154.9K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

24
CJ
Celli JamesDirector
PSQHPSQ Holdings, Inc.
Grant or award
A—
16.7K sh
Jul 9, 2026Sep 17, 2026
traded Jul 9, 2026
+70dSEC Form 4

Evidence

23
MR
Malpani RaghavendraCPO & CTO
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$1.36M
98.4K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

23
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$819K
21.2K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

23
SS
Sprague SuzanneCOO & Global Head of Clearing
CMECME GROUP INC.
Grant or award
A$788K
2,864 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

23
EM
Elshenawy MohamedCTO
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$226K
7,954 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

23
SS
Searby SeanEVP Chief Info. & Ops. Officer
AMALAmalgamated Financial Corp.
Open-market sale · 10b5-1 plan
SELL$158K
3,314 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

23
MF
McCourt Timothy FrancisSr MD Global Head Equity & FX
CMECME GROUP INC.
Grant or award
A$713K
2,592 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

22
CM
Chi MichaelChief Operating Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$398K
14.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

22
HD
Hutchinson Michael DChief Operating Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$1.44M
48.1K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

22
FL
Fitzpatrick LynnePresident and CFO
CMECME GROUP INC.
Grant or award
A$1.12M
4,088 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

22
A
A-6684 Ltd.10% Owner
TOFBTOFUTTI BRANDS INC
Open-market purchase
BUY$3,400
10.0K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

21
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,851 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.70M
27.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
KC
Kozlik ChristenChief Accounting Officer
ACELAccel Entertainment, Inc.
Option exercise
M$22K
1,875 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.08M
17.3K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$266K
4,275 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
SV
Sikri VishalEVP, Commercial
MYGNMYRIAD GENETICS INC
Grant or award
A—
257.7K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

21
BL
Bowman Ronald LeeChief Human Resources Officer
QDELQuidelOrtho Corp
Option exercise
M—
2,566 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
SR
Schmidt Michael ReedDirector
WLTHWEALTHFRONT CORP
Option exercise
M—
2,126 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
HH
Hillabrant Christian HDirector, President and CEO
CCICROWN CASTLE INC.
Option exercise
M—
24.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,800 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
VR
Varrier RajeshPresident Operations CMD India
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Option exercise
M—
272 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
CS
Carter StarlettDirector
GRWGGrowGeneration Corp.
Grant or award
A—
25.0K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

21
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,289 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
25.4K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
HH
Hillabrant Christian HDirector, President and CEO
CCICROWN CASTLE INC.
Option exercise
M—
7,340 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

21
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.30M
20.7K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

20
MC
Marchese John CliffordSr MD, General Counsel
CMECME GROUP INC.
Grant or award
A$216K
784 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

20
ST
Sirmans Dalton TalleyDirector
CUBICustomers Bancorp, Inc.
Grant or award
A$58K
736 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

20
KM
Krasne Robert MorrisDirector
CUBICustomers Bancorp, Inc.
Grant or award
A$67K
847 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

20
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
36.5K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

19
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$174K
6,236 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

18
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
200 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

18
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
300 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

17
GM
Gill MikeDirector
CUBICustomers Bancorp, Inc.
Grant or award
A$49K
625 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

17
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Option exercise
M—
400.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

17
NS
Ninan ShibuChief Accounting Officer
OKTAOkta, Inc.
Option exercise
M—
484 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K